Cytosorbents Corp financial data

Symbol
CTSO on Nasdaq
Location
305 College Road East, Princeton, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 231 % +23%
Quick Ratio 34.1 % +3.71%
Debt-to-equity 315 % +82.4%
Return On Equity -88.8 % +16.8%
Return On Assets -21.4 % +45.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62.8M shares +14.9%
Common Stock, Shares, Outstanding 62.8M shares +15.2%
Entity Public Float 37.1M USD -74.2%
Common Stock, Value, Issued 63K USD +15.6%
Weighted Average Number of Shares Outstanding, Basic 62.8M shares +15.2%
Weighted Average Number of Shares Outstanding, Diluted 62.8M shares +15.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 9.72M USD -35.4%
Operating Income (Loss) -14.1M USD +37.3%
Nonoperating Income (Expense) 1.73M USD -35%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.57M USD -29%
Income Tax Expense (Benefit) -401K USD
Net Income (Loss) Attributable to Parent -10.3M USD +47.9%
Earnings Per Share, Basic 0 USD/shares +50%
Earnings Per Share, Diluted 0 USD/shares +50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.54M USD +32.6%
Accounts Receivable, after Allowance for Credit Loss, Current 7.43M USD +12%
Inventory, Net 4M USD +23.2%
Assets, Current 21.3M USD +28.4%
Property, Plant and Equipment, Net 8.19M USD -11.6%
Operating Lease, Right-of-Use Asset 11.1M USD -4.95%
Other Assets, Noncurrent 3.65M USD -4.06%
Assets 45.8M USD -4.3%
Accounts Payable, Current 3.04M USD +29.8%
Accrued Liabilities, Current 498K USD -41.5%
Contract with Customer, Liability, Current 403K USD
Liabilities, Current 10.1M USD +22.1%
Operating Lease, Liability, Noncurrent 12.1M USD -4.12%
Liabilities 36.7M USD +5.98%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.84M USD -2350%
Retained Earnings (Accumulated Deficit) -307M USD -3.47%
Stockholders' Equity Attributable to Parent 9.02M USD -32.6%
Liabilities and Equity 45.8M USD -4.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.46M USD +28.3%
Net Cash Provided by (Used in) Financing Activities 6.83M USD
Net Cash Provided by (Used in) Investing Activities -47.2K USD +62.8%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 62.8M shares +15.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.35M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.06M USD -25.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 506K USD +154%
Deferred Tax Assets, Valuation Allowance 48.3M USD +6.47%
Deferred Tax Assets, Gross 51.9M USD +5.74%
Operating Lease, Liability 12.6M USD -3.32%
Depreciation 300K USD 0%
Payments to Acquire Property, Plant, and Equipment 2.12K USD -95.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.7M USD +40.3%
Lessee, Operating Lease, Liability, to be Paid 21.2M USD -7.38%
Property, Plant and Equipment, Gross 13.5M USD
Operating Lease, Liability, Current 518K USD +19.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.78M USD +2.98%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.74M USD +2.98%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.61M USD -12.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.82M USD +2.98%
Deferred Tax Assets, Operating Loss Carryforwards 39.3M USD +6.73%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.2M USD +4.11%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.86M USD +3.02%
Operating Lease, Payments 1.82M USD -16.7%
Additional Paid in Capital 320M USD +3.17%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.59M USD -3.25%
Share-based Payment Arrangement, Expense 3.66M USD -15.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%